Alphabet's AI Drug Discovery Unit Isomorphic Labs Secures $5 Billion in Series C Funding
2 day ago / Read about 0 minute
Author:小编   

Isomorphic Labs, Alphabet's AI-driven drug discovery company led by Nobel laureate Demis Hassabis, has announced the completion of a $5 billion Series C funding round. The round was co-led by Greenoaks and Sequoia Capital, with new investor a16z participating. Alphabet continued its substantial investment, while existing backers—including Thrive Capital, MGX, GV, and Temasek—also joined. The proceeds will be used to advance the development of foundational simulation models, scale both internal and partnered drug candidate programs, and build a global AI-powered bioengineering infrastructure.